Silver Spring biotech company is a trailblazer among drug manufacturers
SILVER SPRING, Md. (March 22, 2017) – Comptroller Peter Franchot today honored United Therapeutics Corporation with the Bright Lights Award for Innovation and Entrepreneurship for Montgomery County. The award was presented at a ceremony at the company’s Silver Spring headquarters.
“Maryland is home to some of the most innovative and dynamic entrepreneurs in the world, and United Therapeutics is a shining example of the cutting-edge advancements taking place across our great state,” said Comptroller Franchot.
“Following the lead of its founder, Martine Rothblatt, United Therapeutics has been a trailblazer in the field of drug manufacturing. Martine and United Therapeutics have created hundreds of jobs here in Silver Spring, but more importantly, they have improved, and even saved the lives of thousands of people across the globe.”
The Bright Lights Award recognizes and celebrates innovation in the private and nonprofit sectors that strengthen Maryland’s economy, generate jobs and tax revenue and develop new ideas that more effectively deliver services and products within the marketplace. One winner from each of Maryland’s 23 counties and Baltimore City will receive the award.
“It is a great honor to receive the Bright Lights Award. The entrepreneurial spirit is the lifeblood of United Therapeutics. We would not be the company we are today without access to Maryland’s dynamic, highly educated and highly innovative workforce,” said United Therapeutics Chairman and CEO Martine Rothblatt. “We thank Comptroller Franchot and the State of Maryland for encouraging innovation and empowering entrepreneurs throughout Maryland.”
United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening cardiovascular and infectious diseases and cancer. United Therapeutics has been recognized as one of the Top 10 Corporate Citizens in the field of U.S. drug manufacturing.
MEDIA CONTACT: Joe Shapiro 443-871-2244 (cell), 410-260-7305 (office)